DEL

HYTN Welcomes Health Canada for Audit to Enhance GMP Capabilities

Retrieved on: 
Tuesday, April 9, 2024
Certification, Therapeutic Goods Administration, DEL, Sale, Psilocybin, IND, GMP, Cannabis, Investigational New Drug, Drug development, TGA, FDA, PIC/S, Pharmaceutical industry

VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, “HYTN” or “The Company”), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis, welcomed Health Canada’s conduct of a Drug Establishment License (DEL) audit.

Key Points: 
  • VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, “HYTN” or “The Company”), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis, welcomed Health Canada’s conduct of a Drug Establishment License (DEL) audit.
  • The audit, which aims to expand the Company's Good Manufacturing Practices (GMP) capabilities, follows the recent achievement of GMP certification for HYTN's Kelowna production facility by Australia's Therapeutic Goods Administration (TGA) under the Pharmaceutical Inspection Co-operation Scheme (PIC/S) standard.
  • Securing a DEL will enhance HYTN's current GMP manufacturing capabilities, facilitating the development and sale of additional compounds and product variations.
  • HYTN has demonstrated its ability to manufacture these products according to GMP guidelines.

Dr. Marra Francis Joins Genece Health as Chief Medical Officer

Retrieved on: 
Wednesday, April 3, 2024
Health, Obstetrics, Faculty, Gynaecology, Physician, FACOG, DEL, Memorial Hermann–Texas Medical Center, Lung, Breast, University, MD, Biology, Ovary, Cancer, Liquid biopsy, GeneDx, Occidental College

DEL MAR, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Genece Health, a molecular testing company focused on improving cancer detection for lung, breast, ovarian and other cancers, today announced that Marra Francis, MD, FACOG, has joined the company as its chief medical officer.

Key Points: 
  • DEL MAR, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Genece Health, a molecular testing company focused on improving cancer detection for lung, breast, ovarian and other cancers, today announced that Marra Francis, MD, FACOG, has joined the company as its chief medical officer.
  • Dr. Francis’ past experience also includes serving as head of medical affairs for women's health of Sema4 (now GeneDx); as executive medical director of EverlyWell; and as chief medical officer of Aspira Women's Health.
  • Dr. Francis holds a medical degree from the University of Connecticut Health Center and a bachelor of arts degree in biology from Occidental College.
  • “We are delighted to have Marra join our team at a very exciting time for Genece,” said Greg Gosch, CEO of Genece Heath.

Marchesi Frescobaldi releases 2023 vintage of Tenuta Ammiraglia ALÌE

Retrieved on: 
Tuesday, April 9, 2024
IGT, Temperature, Personality, Culture, Growth, Environment, Gaiole in Chianti, DOC, DEL, Knowledge, DOCG, Foot, Nymph, History, Groundwater, Ear, Fermentation, Wine, POI, LEI, Heart, Sunlight, COME, Vermentino, Nose, NEL, Multimedia, Citrus, UN

MAGLIANO, Italy, April 9, 2024 /PRNewswire-PRWeb/ -- 2023 marks a true milestone for Alìe: its 10th vintage. The first, released in 2014, was reason enough for celebration, but for the current release, Marchesi Frescobaldi is celebrating its rosé by dedicating to it a poetic piece: the Alìade.

Key Points: 
  • The rosé in question is the icon of Tenuta Ammiraglia, on Tuscany's Maremma coast, a blend of the international Syrah and the native Vermentino grape.
  • "Here on the Tenuta Ammiraglia, the vineyards design intriguing geometrical shapes across the hillslopes as they descend to the waters of the Tyrrhenian Sea.
  • Today, we regard with great pride the decision we made to produce these two rosés, Cru Aurea Gran Rosé and Alìe.
  • Marchesi Frescobaldi's nine wine estates are: Castello Pomino (Pomino), Castello Nipozzano (Nipozzano), Tenuta Perano (Gaiole in Chianti), Tenuta Castiglioni (Montespertoli), Tenuta CastelGiocondo (Montalcino), Tenuta Ammiraglia (Magliano in Toscana), Remole (Sieci), Tenuta Calimaia (Montepulciano), and Gorgona.

VSEAT's noseless bike seat to appear on ABC's Shark Tank on April 12

Retrieved on: 
Monday, April 8, 2024
Erectile dysfunction, Nerve, Perineum, Health, DEL, ABC, Groin, Interview, Pressure, SAP, Hulu, Tune, Shark Tank, Television

MARINA DEL REY, Calif., April 8, 2024 /PRNewswire/ -- VSEAT®, creators of the revolutionary noseless and bumpless bicycle seat, is proud to announce its upcoming appearance on ABC's Shark Tank. Watch founders Ani Armstrong and Bryan Visintin present their innovative design to the Sharks on Friday, April 12 at 8 PM ET on ABC and stream on Hulu the following day.

Key Points: 
  • MARINA DEL REY, Calif., April 8, 2024 /PRNewswire/ -- VSEAT® , creators of the revolutionary noseless and bumpless bicycle seat, is proud to announce its upcoming appearance on ABC's Shark Tank.
  • That is until Ani cited persistent pain from her bike seat.
  • Tune in to ABC on Friday, April 12 at 8 PM ET/PT to watch the VSEAT® on Shark Tank.
  • For more information or to arrange an interview with the founders, please email Andrew Luftglass at [email protected] .

Genece Health Announces New Performance Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

Retrieved on: 
Wednesday, March 20, 2024
Liquid biopsy, DEL, Lung, Abstract, AACR, Interpretation, Breast, Cancer

DEL MAR, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Genece Health, a molecular testing company focused on improving cancer screening for lung, breast, ovarian and other cancers, today announced that four abstracts demonstrating their deep-learning AI and liquid biopsy technology’s performance were selected for presentation at the upcoming 2024 American Association for Cancer Research (AACR), taking place April 5-10, 2024, in San Diego, CA.

Key Points: 
  • DEL MAR, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Genece Health, a molecular testing company focused on improving cancer screening for lung, breast, ovarian and other cancers, today announced that four abstracts demonstrating their deep-learning AI and liquid biopsy technology’s performance were selected for presentation at the upcoming 2024 American Association for Cancer Research (AACR), taking place April 5-10, 2024, in San Diego, CA.
  • This will be the first time performance data from the company will be shared publicly.
  • The abstracts will be available on the AACR website and poster presentation details can be found below.
  • Session Title: Advances in Genomic Sequencing Platforms, Methodologies, and Interpretation 1

Ibogaine By David Dardashti Explores Chemistry of Treatment for Long Term Opiate Abuse

Retrieved on: 
Friday, March 15, 2024
Ibogaine, DEL, Opioid, Research, Chemical engineering, Medicine, Pharmaceutical industry

PLAYA DEL CARMEN, Mexico, March 14, 2024 (GLOBE NEWSWIRE) -- David Dardashti describes his discovery of ibogaine treatment for long term opiates.

Key Points: 
  • PLAYA DEL CARMEN, Mexico, March 14, 2024 (GLOBE NEWSWIRE) -- David Dardashti describes his discovery of ibogaine treatment for long term opiates.
  • This in turn can lead to a more successful ibogaine treatment when compared to short-term opiate treatments.
  • David discovered an effective combination of medications that can effectively disconnect the neurological pathways created by long-term opiate use, to enable a successful ibogaine treatment prior to the use of ibogaine.
  • Ibogaine By David Dardashti is seeking out qualified clinicians to explore the powerful effects of pure ibogaine hydrochloride on long-term opiate abuse.

Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders

Retrieved on: 
Wednesday, March 27, 2024
ARRW, Special, Shareholder, DEL, Arrowroot, Finance Secretary (India)

MARINA DEL REY, Calif., March 26, 2024 /PRNewswire/ -- Arrowroot Acquisition Corp. ("Arrowroot" or the "Company") (NASDAQ: ARRWU, ARRW, ARRWW) today announced that its special meeting of stockholders ("Special Meeting") will be postponed from its scheduled time of 9:00 a.m. Eastern Time on March 28, 2024 to 9:00 a.m. Eastern Time on April 1, 2024.

Key Points: 
  • MARINA DEL REY, Calif., March 26, 2024 /PRNewswire/ -- Arrowroot Acquisition Corp. ("Arrowroot" or the "Company") (NASDAQ: ARRWU, ARRW, ARRWW) today announced that its special meeting of stockholders ("Special Meeting") will be postponed from its scheduled time of 9:00 a.m. Eastern Time on March 28, 2024 to 9:00 a.m. Eastern Time on April 1, 2024.
  • The Special Meeting can still be accessed virtually by visiting www.virtualshareholdermeeting.com/ARRW2024SM .
  • You will need the 12-digit meeting control number that is printed on your proxy card to enter the Special Meeting.
  • The record date for the Special Meeting remains March 13, 2024.

Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders and New Record Date of Special Meeting of Stockholders

Retrieved on: 
Wednesday, March 13, 2024
ARRW, Common stock, Arrowroot, Proxy, Shareholder, Telephone, DEL, Internet, Special, Finance Secretary (India)

You will need the 12-digit meeting control number that is printed on your proxy card to enter the Special Meeting.

Key Points: 
  • You will need the 12-digit meeting control number that is printed on your proxy card to enter the Special Meeting.
  • The record date for the Special Meeting will be March 13, 2024.
  • The previous submission of proxies also will not affect your right to vote in the event that you attend the Special Meeting.
  • Please note, however, that attendance alone at the Special Meeting without voting will not be sufficient to revoke a previously authorized proxy.

FRESH DEL MONTE LAUNCHES PERSONAL SIZE PRECIOUS HONEYGLOW™ PINEAPPLE EXCLUSIVELY THROUGH MELISSA'S PRODUCE

Retrieved on: 
Wednesday, March 13, 2024
Carbon, USDA, Taste, Fresh Del Monte Produce, Vegetable, DEL, Internal, Sale, Economic Research Service, Mini, Horticulture

CORAL GABLES, Fla., March 13, 2024 /PRNewswire/ -- The world's leading vertically integrated producer of high-quality fresh and fresh-cut fruit and vegetables is joining forces with the nation's largest distributor of specialty produce to offer fresh pineapple lovers an entirely new size option.

Key Points: 
  • New personal size pineapple offering is part of Fresh Del Monte's Honeyglow® line, which are harvested at peak ripeness to deliver a distinctly sweet taste and radiant color.
  • Precious Honeyglow™ is the most compact pineapple in Del Monte history, weighing between 1.5 and 2 pounds, about half the average weight of a full size traditional fresh pineapple.
  • The smaller Del Monte® Precious Honeyglow™ is designed to offer consumers more choices in the variety and size of their fresh whole pineapple, to suit taste preferences and reduce food waste.
  • As with all Del Monte® pineapples and other Fresh Del Monte products, Precious Honeyglow® pineapples sustainable practices for planting, harvesting and transporting.

Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders

Retrieved on: 
Wednesday, February 21, 2024
DEL, ARRW, Finance Secretary (India), Shareholder, Arrowroot, Special

MARINA DEL REY, Calif., Feb. 21, 2024 /PRNewswire/ -- Arrowroot Acquisition Corp. ("Arrowroot" or the "Company") (NASDAQ: ARRWU, ARRW, ARRWW) today announced that its special meeting of stockholders ("Special Meeting") will be postponed from its scheduled time of 9:00 a.m. Eastern Time on February 22, 2024 to 9:00 a.m. Eastern Time on March 15, 2024.

Key Points: 
  • MARINA DEL REY, Calif., Feb. 21, 2024 /PRNewswire/ -- Arrowroot Acquisition Corp. ("Arrowroot" or the "Company") (NASDAQ: ARRWU, ARRW, ARRWW) today announced that its special meeting of stockholders ("Special Meeting") will be postponed from its scheduled time of 9:00 a.m. Eastern Time on February 22, 2024 to 9:00 a.m. Eastern Time on March 15, 2024.
  • The Special Meeting can still be accessed virtually by visiting www.virtualshareholdermeeting.com/ARRW2024SM .
  • You will need the 12-digit meeting control number that is printed on your proxy card to enter the Special Meeting.
  • The record date for the Special Meeting remains January 18, 2024.